| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1034/J.1600-0447.2000.101001011.X |
| P698 | PubMed publication ID | 10674946 |
| P50 | author | Poul Videbech | Q25820346 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | major depressive disorder | Q42844 |
| P304 | page(s) | 11-20 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Acta Psychiatrica Scandinavica | Q4033348 |
| P1476 | title | PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review | |
| P478 | volume | 101 |
| Q96340745 | 18 F-FDG PET/CT brain glucose metabolism as a marker of different types of depression comorbidity in chronic heart failure patients with impaired systolic function |
| Q91198061 | A novel concurrent TMS-fMRI method to reveal propagation patterns of prefrontal magnetic brain stimulation |
| Q48277421 | A single photon emission computerized tomography (SPECT) study of regional cerebral blood flow in bipolar disorder |
| Q33718002 | Abnormal resting state corticolimbic blood flow in depressed unmedicated patients with major depression: a (15)O-H(2)O PET study |
| Q35204087 | Affective disorders, antidepressant drugs and brain metabolism |
| Q51959549 | Alterations in prefrontal cortical activity in the course of treatment for late-life depression as assessed on near-infrared spectroscopy. |
| Q30557207 | Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression |
| Q28206154 | Ampakines reduce methamphetamine-driven rotation and activate neocortex in a regionally selective fashion |
| Q39186841 | An astroglial basis of major depressive disorder? An overview. |
| Q27491346 | An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes? |
| Q92062185 | Anatomical Connectivity-Based Strategy for Targeting Transcranial Magnetic Stimulation as Antidepressant Therapy |
| Q44292634 | Audioverbal cognitive dysfunction in depression. Factors involved |
| Q35592041 | Baseline brain metabolism in resistant depression and response to transcranial magnetic stimulation |
| Q30799242 | Biological predictors of treatment response in affective illness |
| Q34660410 | Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory |
| Q43713436 | Brain metabolic changes associated with symptom factor improvement in major depressive disorder |
| Q35684600 | Brain systems underlying susceptibility to helplessness and depression |
| Q37767259 | Case for and against specificity of depression in Alzheimer's disease |
| Q48086194 | Cell type-specific in vivo expression of genes encoding signalling molecules in the brain in response to chronic mild stress and chronic treatment with fluoxetine |
| Q44317823 | Cerebral blood flow in depressed patients: a methodological comparison of statistical parametric mapping and region of interest analyses |
| Q46298135 | Cerebral glucose metabolism abnormalities in patients with major depressive symptoms in pre-dialytic chronic kidney disease: statistical parametric mapping analysis of F-18-FDG PET, a preliminary study |
| Q45000097 | Changes in brain metabolism associated with remission in unipolar major depression |
| Q50882466 | Changes in regional cerebral blood flow demonstrated by 99mTc-HMPAO SPECT in euthymic bipolar patients. |
| Q41816322 | Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression |
| Q30906677 | Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift |
| Q34864441 | Chronic exposure to light reverses the effect of maternal separation on proteins in the prefrontal cortex |
| Q57292160 | Chronic social stress-induced hyperglycemia in mice couples individual stress susceptibility to impaired spatial memory |
| Q43275543 | Chronic therapy with citalopram decreases regional cerebral glucose utilization in OBX, and not sham-operated, rats: an autoradiographic study |
| Q43296887 | Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation |
| Q38732918 | Co-altered functional networks and brain structure in unmedicated patients with bipolar and major depressive disorders |
| Q46429619 | Cognitive control adjustments and conflict adaptation in major depressive disorder. |
| Q52011078 | Cognitive deficits in major depression. |
| Q30351392 | Cognitive neuropsychiatry: conceptual, methodological and philosophical perspectives. |
| Q37165446 | Combination rapid transcranial magnetic stimulation in treatment refractory depression |
| Q44220441 | Comment on "Regional cerebral glucose utilization in patients with a range of severities of unipolar depression". |
| Q52151983 | Common behaviors alterations after extremely low-frequency electromagnetic field exposure in rat animal model. |
| Q51900615 | Comorbid anxiety corresponds with neuropsychological dysfunction in unipolar depression. |
| Q37854101 | Connectivity between mitochondrial functions and psychiatric disorders |
| Q35108480 | Depression and HIV Disease |
| Q39300904 | Differential levels of brain amino acids in rat models presenting learned helplessness or non-learned helplessness |
| Q47969516 | Differentiating between clinical and behavioral phenotypes in first-episode psychosis during maintenance of visuospatial working memory. |
| Q33773602 | Distinctions between bipolar and unipolar depression |
| Q37021767 | Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence |
| Q42519375 | Early changes in brain FDG metabolism during anticancer therapy in patients with pharyngeal cancer. |
| Q47607893 | Effects of L-theanine on anxiety-like behavior, cerebrospinal fluid amino acid profile, and hippocampal activity in Wistar Kyoto rats |
| Q43577900 | Effects of bupropion SR on anterior paralimbic function during waking and REM sleep in depression: preliminary findings using |
| Q91917924 | Environmental enrichment effects after early stress on behavior and functional brain networks in adult rats |
| Q48258654 | Evaluation of regional cerebral blood flow changes in panic disorder with Tc99m-HMPAO SPECT. |
| Q47974603 | Executive control deficit in depression: event-related potentials in a Go/Nogo task |
| Q38416343 | Executive function improvement upon remission of recurrent unipolar depression |
| Q92016927 | Far-infrared Ray-mediated Antioxidant Potentials are Important for Attenuating Psychotoxic Disorders |
| Q34391633 | Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects |
| Q36061734 | Frontostriatal functional connectivity in major depressive disorder |
| Q47815343 | Functional connectivity of the left DLPFC to striatum predicts treatment response of depression to TMS. |
| Q57934902 | Functional near Infrared Spectroscopy in Psychiatry: A Critical Review |
| Q88117834 | Glucose transporter 2 mediates the hypoglycemia-induced increase in cerebral blood flow |
| Q46698279 | HPA axis normalization, estimated by DEX/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures |
| Q34208604 | Hyperforin promotes mitochondrial function and development of oligodendrocytes. |
| Q36031835 | Hypothalamic Proteomic Analysis Reveals Dysregulation of Glutamate Balance and Energy Metabolism in a Mouse Model of Chronic Mild Stress-Induced Depression |
| Q36508139 | Identification and validation of urinary metabolite biomarkers for major depressive disorder |
| Q44555835 | Impulsivity and prefrontal hypometabolism in borderline personality disorder |
| Q33708492 | Increased occipital delta dipole density in major depressive disorder determined by magnetoencephalography. |
| Q35681597 | Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis |
| Q64951069 | Intracranial compliance is associated with symptoms of orthostatic intolerance in chronic fatigue syndrome. |
| Q60915137 | Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study |
| Q35111565 | Is treatment-resistant depression a unique subtype of depression? |
| Q31131776 | Lance-Adams syndrome: a report of two cases |
| Q33816541 | Medial prefrontal cortex activity during memory encoding of pictures and its relation to symptomatic improvement after citalopram treatment in patients with major depression |
| Q45875462 | Memory assessment and depression: testing for factor structure and measurement invariance of the Wechsler Memory Scale-Fourth Edition across a clinical and matched control sample |
| Q89273094 | Metabolic fate of glucose in the brain of APP/PS1 transgenic mice at 10 months of age: a 13C NMR metabolomic study |
| Q41449740 | Microstructural Abnormalities of Basal Ganglia and Thalamus in Bipolar and Unipolar Disorders: A Diffusion Kurtosis and Perfusion Imaging Study |
| Q48235632 | Minocycline protects against oxidative damage and alters energy metabolism parameters in the brain of rats subjected to chronic mild stress |
| Q47892213 | Mismatch in cerebral blood flow and glucose metabolism after the forced swim stress in rats. |
| Q35577654 | Mitochondria DNA change and oxidative damage in clinically stable patients with major depressive disorder |
| Q55266121 | Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression. |
| Q38213177 | Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders |
| Q37216404 | Mitochondria in neuroplasticity and neurological disorders |
| Q38753778 | Mitochondrial Dysfunction in Depression |
| Q38733069 | Mitochondrial genetic haplogroups and depressive symptoms: A large study among people in North America |
| Q34994220 | Mitochondrial involvement in psychiatric disorders |
| Q44051672 | Mitochondrial plasticity of the hippocampus in a genetic rat model of depression after antidepressant treatment |
| Q30582601 | Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression. |
| Q33418617 | Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder |
| Q39427752 | Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review |
| Q34655185 | Morphological brain changes in depression: can antidepressants reverse them? |
| Q47559443 | Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis. |
| Q30504497 | N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice |
| Q57935222 | Nah-Infrarot-Spektroskopie in der Psychiatrie |
| Q30981655 | Neurobiological findings in bipolar II disorder compared with findings in bipolar I disorder |
| Q46652532 | Neuroprotective effect of chronic lithium treatment against hypoxia in specific brain regions with upregulation of cAMP response element binding protein and brain-derived neurotrophic factor but not nerve growth factor: comparison with acute lithium |
| Q30989979 | Neuropsychological dysfunction in bipolar affective disorder: a critical opinion |
| Q36803388 | Not all depression is created equal: sex interacts with disease to precipitate depression |
| Q35475165 | Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome |
| Q44298286 | Opposite metabolic changes in the habenula and ventral tegmental area of a genetic model of helpless behavior. |
| Q45031158 | Ovarian steroids influence cerebral glucose transporter expression in a region- and isoform-specific pattern. |
| Q35692959 | Positron emission tomography imaging in depression: a neural systems perspective |
| Q43750655 | Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders |
| Q48580643 | Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulate cortex: a voxel-based single photon emission computed tomography (SPECT) study. |
| Q58707532 | Putative Inflammatory Sensitive Mechanisms Underlying Risk or Resilience to Social Stress |
| Q27317305 | Rapid development of image analysis research tools: Bridging the gap between researcher and clinician with pyOsiriX. |
| Q47333083 | Reduced negative BOLD responses in the default-mode network and increased self-focus in depression |
| Q36575460 | Reduced posterior mesofrontal cortex activation by risky rewards in substance-dependent patients |
| Q89338439 | Regional alterations of cerebral [18F]FDG metabolism in the chronic unpredictable mild stress- and the repeated corticosterone depression model in rats |
| Q24564775 | Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus |
| Q35962076 | Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis |
| Q44411164 | Salivary cortisol patterns and cognitive speed in major depression: a comparison with allergic rhinitis and healthy control subjects |
| Q38152452 | Self-referential processing, rumination, and cortical midline structures in major depression |
| Q39171620 | Sex-dependent mental illnesses and mitochondria |
| Q27006485 | Signal Transduction in Astrocytes during Chronic or Acute Treatment with Drugs (SSRIs, Antibipolar Drugs, GABA-ergic Drugs, and Benzodiazepines) Ameliorating Mood Disorders |
| Q48127609 | Sleep difficulties are associated with increased symptoms of psychopathology |
| Q36445094 | Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. |
| Q48131094 | State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge |
| Q48896324 | Structural brain abnormalities in unselected in-patients with major depression. |
| Q48559126 | The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. |
| Q48281058 | The Danish PET/depression project: cognitive function and regional cerebral blood flow |
| Q24579629 | The Danish PET/depression project: performance on Stroop's test linked to white matter lesions in the brain |
| Q48315212 | The Danish PET/depression project: poor verbal fluency performance despite normal prefrontal activation in patients with major depression |
| Q41286620 | The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence |
| Q55262466 | The Risk Factors of the Alcohol Use Disorders-Through Review of Its Comorbidities. |
| Q53077511 | The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia. |
| Q34991028 | The cerebral glucose-fatty acid cycle: evolutionary roots, regulation, and (patho)physiological importance |
| Q35246024 | The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders |
| Q30656863 | The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review |
| Q37138379 | The nosologic relationship between generalized anxiety disorder and major depression |
| Q28269179 | The other face of depression, reduced positive affect: the role of catecholamines in causation and cure |
| Q36288255 | The potential of transcranial photobiomodulation therapy for treatment of major depressive disorder |
| Q42080300 | The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder |
| Q35374637 | The relationship between somatic and cognitive-affective depression symptoms and error-related ERPs |
| Q37785512 | The role of mitochondrial dysfunction in psychiatric disease |
| Q34268488 | The role of the brain reward system in depression |
| Q24561923 | The role of the hippocampus in the pathophysiology of major depression |
| Q36335760 | The use of fluorine-18 fluorodeoxyglucose positron emission tomography for imaging human motor neuronal activation in the brain |
| Q48364470 | The value of ethyl cysteinate dimer single photon emission computed tomography in predicting antidepressant treatment response in patients with major depression |
| Q34013923 | Toward dysfunctional connectivity: a review of neuroimaging findings in pediatric major depressive disorder |
| Q57808859 | Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial |
| Q80433360 | Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder |
| Q96431716 | Validating a functional near-infrared spectroscopy diagnostic paradigm for Major Depressive Disorder |
| Q73643708 | Visuo-motor coordination is normal in patients with major depression |
| Q80998963 | [Effectiveness of Integrated Psychological Therapy for schizophrenia patients. A meta-analysis including 28 independent studies] |
Search more.